Stefania Petrosino Selected Research

OMDM 169

1/2009

Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefania Petrosino Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 06/2007
12	Obesity 01/2022 - 08/2006
9	Pain (Aches) 01/2015 - 03/2006
8	Hyperalgesia 01/2018 - 10/2006
6	Neuralgia (Stump Neuralgia) 12/2019 - 10/2006
5	Neoplasms (Cancer) 08/2012 - 01/2008
4	Colitis 01/2021 - 05/2007
4	Insulin Resistance 11/2011 - 11/2009
3	Neuroinflammatory Diseases 01/2022 - 01/2019
3	Weight Loss (Weight Reduction) 01/2014 - 08/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2011 - 08/2006
2	Neuroblastoma 01/2022 - 01/2009
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019 - 01/2017
2	Allergic Contact Dermatitis 01/2018 - 06/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 06/2010
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 07/2005
2	Hyperinsulinism (Hyperinsulinemia) 01/2014 - 08/2006
2	Body Weight (Weight, Body) 11/2013 - 01/2011
2	Schizophrenia (Dementia Praecox) 02/2011 - 06/2009
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2010 - 05/2007
2	Epilepsy (Aura) 10/2009 - 08/2006
2	Vomiting 06/2009 - 09/2005
2	Hyperglycemia 04/2008 - 08/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Leukemia 12/2019
1	Edema (Dropsy) 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Dermatitis 11/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Bronchial Hyperreactivity 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Respiratory Hypersensitivity 01/2015
1	Atopic Dermatitis (Atopic Eczema) 01/2014
1	Pruritus (Itching) 01/2014
1	Anorexia 11/2013
1	Absence Epilepsy (Childhood Absence Epilepsy) 06/2013
1	Glioma (Gliomas) 08/2012

Drug/Important Bio-Agent (IBA)

34	EndocannabinoidsIBA 12/2020 - 07/2005
13	palmidrolIBA 01/2022 - 01/2008
13	CannabinoidsIBA 01/2018 - 05/2006
9	anandamide (arachidonylethanolamide)IBA 01/2013 - 07/2005
8	EnzymesIBA 01/2019 - 09/2005
6	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2015 - 10/2006
6	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 06/2013 - 09/2005
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 06/2013
4	CytokinesIBA 01/2022 - 11/2011
4	LipidsIBA 12/2020 - 01/2014
4	CarrageenanIBA 01/2018 - 06/2010
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2013 - 09/2005
4	Dopamine (Intropin)FDA LinkGeneric 10/2009 - 07/2005
3	Substance PIBA 12/2019 - 09/2005
3	CB2 Cannabinoid ReceptorIBA 01/2018 - 03/2010
3	LigandsIBA 01/2015 - 03/2010
3	RimonabantIBA 11/2013 - 07/2005
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2013 - 06/2007
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2013 - 09/2005
3	Serotonin (5 Hydroxytryptamine)IBA 06/2010 - 09/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 09/2005
2	DinitrobenzenesIBA 01/2021 - 11/2009
2	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2021 - 01/2015
2	Chemokine CCL8IBA 01/2021 - 01/2018
2	Sulfonic AcidsIBA 01/2021 - 11/2009
2	Neuroprotective AgentsIBA 01/2019 - 01/2017
2	2-pentadecyl-2-oxazolineIBA 01/2019 - 01/2017
2	CannabidiolIBA 01/2018 - 11/2009
2	Analgesics (Analgesic Drugs)IBA 01/2015 - 08/2011
2	PPAR alphaIBA 01/2015 - 01/2011
2	Insulin (Novolin)FDA Link 01/2014 - 11/2009
2	LeptinIBA 06/2013 - 04/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 06/2013 - 10/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2013 - 01/2011
2	Phencyclidine (Angel Dust)IBA 02/2011 - 06/2009
2	arachidonoylserotoninIBA 06/2010 - 01/2008
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	AmidesIBA 12/2020
1	Poly I-CIBA 01/2018
1	ChemokinesIBA 01/2018
1	co-ultraPEALutIBA 01/2017
1	DinitrofluorobenzeneIBA 11/2016
1	dinitrobenzenesulfonic acidIBA 01/2015
1	diacereinIBA 01/2015
1	AllergensIBA 01/2015
1	Ion Channels (Ion Channel)IBA 01/2015
1	OvalbuminIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2014
1	Tryptases (Tryptase)IBA 01/2014
1	OrexinsIBA 06/2013
1	CaspasesIBA 11/2012
1	AMPA Receptors (AMPA Receptor)IBA 11/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2012
1	Glutamic Acid (Glutamate)FDA Link 11/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2012
1	TRPV Cation ChannelsIBA 08/2012
1	arvanilIBA 08/2012

Therapy/Procedure

3	Therapeutics 08/2012 - 02/2010
1	Oral Administration 12/2020